---
schema_version: "secwatch.filing_event.v1"
accession: "0000849146-24-000017"
form_type: "8-K"
ticker: "LFVN"
cik: "0000849146"
company_name: "Lifevantage Corp"
filed_at: "2024-01-30T23:59:59+00:00"
generated_at: "2026-06-06T15:31:52.804952+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# LifeVantage Q2 revenue down 3.8% to $51.6M; adjusted EBITDA up 289%; lowers FY revenue guidance, raises EPS guide

## Summary
- Revenue $51.6M (-3.8% YoY); Americas -1.6%, Asia/Pacific & Europe -10.0% (-8.0% constant currency).
- Net loss $0.7M ($0.05 loss per share) vs $1.1M loss; adjusted EPS $0.10 vs -$0.07.
- Adjusted EBITDA $3.1M (+289%); margin improved 450 bps to 6%.
- FY2024 revenue guidance cut to $207-213M from $216-226M; adjusted EPS raised to $0.57-0.67 from $0.52-0.62.
- Declares $0.035/share dividend payable March 15, 2024; repurchased 0.4M shares for $2.7M in H1.

## SEC filing metadata
- accession: 0000849146-24-000017
- form_type: 8-K
- ticker: LFVN
- cik: 0000849146
- company_name: Lifevantage Corp
- filed_at: 2024-01-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/849146/000084914624000017/0000849146-24-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/849146/000084914624000017/lfvn-20240130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000849146-24-000017
- JSON: https://secwatch.observer/filing/0000849146-24-000017.json
- Plain text: https://secwatch.observer/filing/0000849146-24-000017.txt

## Key facts
- Earnings Releases
  Lifevantage Corp reported second fiscal quarter ended December 31, 2023 results: revenue $51.6 million, net income $0.7 million, EPS $0.05 per diluted share.
  - Period: second fiscal quarter ended December 31, 2023
  - Revenue: $51.6 million
  - Net income: $0.7 million
  - EPS: $0.05 per diluted share
  - Result: reported results
  source text: Second Quarter Fiscal 2024 Summary*: • Revenue of $51.6 million, a decrease of 3.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, second quarter revenue was down approximately 3.4%; • Revenue in the Americas decreased 1.6%, and revenue in Asia/Pacific & Europe decreased 10.0%. Excluding the negative impact of foreign currency fluctuations, second quarter revenue in Asia/Pacific & Europe decreased approximately 8.0%; • Net loss per diluted share was $0.05, versus net loss of $0.08 per diluted share a year ago; • Adjusted earnings per diluted share was $0.10, compared to adjusted loss per share of $0.07 a year ago; and • Adjusted EBITDA increased 289.0% to $3.1 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/849146/000084914624000017/0000849146-24-000017-index.htm
- Earnings Releases
  Lifevantage Corp reported fiscal year 2024 results: revenue $207 million to $213 million, EPS $0.57 to $0.67.
  - Period: fiscal year 2024
  - Revenue: $207 million to $213 million
  - EPS: $0.57 to $0.67
  - Result: guidance update
  source text: The Company expects to generate revenue in the range of $207 million to $213 million in fiscal year 2024, down from the previous range of $216 million to $226 million, and adjusted EBITDA of $16 million to $18 million, with adjusted earnings per share in the range of $0.57 to $0.67, up from the previous range of $0.52
  evidence_url: https://www.sec.gov/Archives/edgar/data/849146/000084914624000017/0000849146-24-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
